Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

BION Treatment of Dysphagia After Radical Head-Neck Surgery

1 giugno 2015 aggiornato da: Gerald E. Loeb, M.D., University of Southern California

BION Stimulation to Improve Swallowing Function After Radical Head-neck Surgery and Follow-up Chemoradiation Therapy

The primary goal of the proposed study is to improve the long-term swallowing capabilities of subjects undergoing radical or modified radical neck surgeries followed by chemoradiation therapy (CRT), by more selective stimulation of the swallowing muscles using implanted microstimulators called BIONs.

Panoramica dello studio

Stato

Completato

Condizioni

Descrizione dettagliata

Disseminated head and neck cancer is a serious, often life-threatening medical problem that requires immediate and heroic therapeutic intervention. Treatment typically begins with extensive surgery followed as soon as possible by an intense series of radiation and chemotherapy treatments. Typically the patient has recovered sufficiently from the surgery by 2-4 weeks to withstand the new assaults that will result from chemoradiation therapy (CRT), which kills cancer cells, but also causes muscle atrophy and scarring that can permanently ruin the swallowing apparatus. Thus, the majority of patients who undergo CRT develop severe swallowing problems, called dysphagia, that typically becomes worse by about 3-4 weeks following the beginning of CRT. In anticipation of all of these problems, subjects have a tube placed in the stomach (gastrostomy tube) so that they can be fed through the tube in the immediate postoperative period when the incision is fragile and when dysphagia develops during CRT. Clearly the management of dysphagia during CRT is of primary importance to the prognosis of the patient. Recent studies have shown that electrical activation of swallowing muscles during and after CRT can improve the prognosis by reducing dysphagia, but currently available technology requires the current to be applied transcutaneously. Thus, large electrical currents must be applied to the damaged skin, and the electrical stimulation that results is uncomfortable, diffuse and uncontrolled. It is difficult with this approach to stimulate the deepest muscles that are the preferred targets for the stimulation. The primary goal of the proposed study is to improve the long-term swallowing capabilities of subjects undergoing radical or modified radical neck surgeries followed by CRT, by more selective stimulation of the swallowing muscles using implanted microstimulators called BIONs. The mechanism of the electrical stimulation is thought to be the same as that for other rehabilitative approaches to muscle, i.e.,to help maintain strength and mobility of these muscles during the post-operative treatment period when the muscles are not being used and are particularly vulnerable to scarring and atrophy.

Two different paradigms of stimulation will be employed in order to compare and gain insight into the mechanisms involved in the remediation. This study also presents the opportunity to examine directly the changes in muscle produced by stimulation. Thus, a secondary research goal of the study that takes advantage of the opportunity presented by this intervention is to gain insight into the cellular changes that are thought to underlie the effects of radiation and subsequent electrical stimulation. By implanting these devices at the time of the neck surgeries, it is possible to target the nerves that supply specific muscles and thus ensure the excitation of specific muscles using current strengths much lower than those required with transcutaneous stimulation.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

4

Fase

  • Fase 1

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • California
      • Los Angeles, California, Stati Uniti, 90033
        • USC University Hospitals

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 70 anni (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  1. Subject has Stage 3-4 cancer of the oral cavity or oropharynx with a primary tumor size of 1-6 cm (T1-T3) and neck lymph node metastases.
  2. Subject is above 18 years old.
  3. Attending physician considers the subject to be an appropriate candidate for surgery and chemoradiation therapy.
  4. Subject is mentally capable of understanding the goals and the application of therapy or whenever in doubt, is able to pass the Minimental State (MMSE) test.
  5. Subject is able to apply the therapy without help or with the help of a caregiver.
  6. Subject is willing and capable of giving informed consent.
  7. Subject is willing and capable of traveling to testing center at the necessary points in the schedule of testing.

Exclusion Criteria:

  1. Subject is pregnant, nursing, or planning to become pregnant in the next 12 months.
  2. Subject has an electronic implant (e.g. cardiac pacemaker, etc.).
  3. Subject has large metallic implant (e.g. skull plates) in the head or neck region (small metal implants, such as bone screws, metal sutures or dental parts are acceptable).
  4. Subject has had previous surgery or disease of the upper esophageal tract or vocal structures that have changed the normal anatomical relationships of the epiglottal region, making swallowing abnormal, or have damaged the nerves of the target muscles that control swallowing, making it difficult to stimulate the swallowing muscles effectively.
  5. Subject has an active immunosuppressive disorder such as AIDS that may result in muscle wasting, or has a neurological injury or disease that affects the function of the nerves or neuromuscular endplates in the throat, such as myasthenia gravis or multiple sclerosis. The subject has a significant concurrent or recently diagnosed (less than 3 months) medical condition that, in the opinion of the medical investigator, could affect the ability of the patient to tolerate or complete the study. Such conditions might include a second malignancy, heart disease or stroke.
  6. Subject has a major psychological disorder, such as poorly controlled schizophrenia or paranoia, that may affect the clinical interactions with the subject or result in poor compliance with the therapy.
  7. Subject has a significant respiratory problem such as asthma or chronic obstructive lung disease requiring regular use of inhaled or systemic corticosteroids. Subject has a tracheostomy or has had previous surgery on the trachea that has damaged the swallowing muscles or made inhalation of swallowed food more likely.
  8. Subject is currently enrolled in another investigational study.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Low Stimulation
The first group will have a stimulation paradigm employing low-frequency (1-5 pps), supramaximal "twitch" stimulation.
The second group will have a "High Stimulation" paradigm at a frequency that produces strong, fused contractions (20-30pps) for a total of 1h/d, also in two spaced sessions. Stimulation intensity will be adjusted to produce the strongest contractions that are tolerated.
The first group will have a stimulation paradigm employing low-frequency (1-5 pps), supramaximal "twitch" stimulation. The period of the stimulation will probably be short for the first sessions as the muscles gain strength and fatigue resistance, but will eventually be 60 minutes per day in two spaced sessions of about 30 minutes each.
A third group of experimental subjects will have a standardized program of voluntary swallowing exercises. Their BIONs will not be activated until they have worsening of dysphagia, and thus are considered to have failed conventional therapy.
Sperimentale: High Stimulation
The second group will have a "High Stimulation" paradigm at a frequency that produces strong, fused contractions (20-30pps) for a total of 1h/d, also in two spaced sessions.
The second group will have a "High Stimulation" paradigm at a frequency that produces strong, fused contractions (20-30pps) for a total of 1h/d, also in two spaced sessions. Stimulation intensity will be adjusted to produce the strongest contractions that are tolerated.
The first group will have a stimulation paradigm employing low-frequency (1-5 pps), supramaximal "twitch" stimulation. The period of the stimulation will probably be short for the first sessions as the muscles gain strength and fatigue resistance, but will eventually be 60 minutes per day in two spaced sessions of about 30 minutes each.
A third group of experimental subjects will have a standardized program of voluntary swallowing exercises. Their BIONs will not be activated until they have worsening of dysphagia, and thus are considered to have failed conventional therapy.
Comparatore placebo: Control Group
A third group of experimental subjects will have a standardized program of voluntary swallowing exercises.
The second group will have a "High Stimulation" paradigm at a frequency that produces strong, fused contractions (20-30pps) for a total of 1h/d, also in two spaced sessions. Stimulation intensity will be adjusted to produce the strongest contractions that are tolerated.
The first group will have a stimulation paradigm employing low-frequency (1-5 pps), supramaximal "twitch" stimulation. The period of the stimulation will probably be short for the first sessions as the muscles gain strength and fatigue resistance, but will eventually be 60 minutes per day in two spaced sessions of about 30 minutes each.
A third group of experimental subjects will have a standardized program of voluntary swallowing exercises. Their BIONs will not be activated until they have worsening of dysphagia, and thus are considered to have failed conventional therapy.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Lasso di tempo
swallowing function
Lasso di tempo: prior surgery, 2w post surgery, end of radiation recovery, end of rehab
prior surgery, 2w post surgery, end of radiation recovery, end of rehab

Misure di risultato secondarie

Misura del risultato
Lasso di tempo
blood test, ease of swallowing questionnaire
Lasso di tempo: prior surgery, 2w post surgery, end of radiation recovery, end of rahab
prior surgery, 2w post surgery, end of radiation recovery, end of rahab

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Gerald Loeb, MD, University of Southern California

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio

1 ottobre 2007

Completamento primario (Effettivo)

1 dicembre 2008

Completamento dello studio (Effettivo)

1 dicembre 2008

Date di iscrizione allo studio

Primo inviato

25 febbraio 2008

Primo inviato che soddisfa i criteri di controllo qualità

25 febbraio 2008

Primo Inserito (Stima)

5 marzo 2008

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Stima)

3 giugno 2015

Ultimo aggiornamento inviato che soddisfa i criteri QC

1 giugno 2015

Ultimo verificato

1 giugno 2015

Maggiori informazioni

Termini relativi a questo studio

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su BION

3
Sottoscrivi